David G. Myszka

17.6k total citations · 2 hit papers
133 papers, 13.2k citations indexed

About

David G. Myszka is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging and Biomedical Engineering. According to data from OpenAlex, David G. Myszka has authored 133 papers receiving a total of 13.2k indexed citations (citations by other indexed papers that have themselves been cited), including 100 papers in Molecular Biology, 49 papers in Radiology, Nuclear Medicine and Imaging and 21 papers in Biomedical Engineering. Recurrent topics in David G. Myszka's work include Monoclonal and Polyclonal Antibodies Research (49 papers), Advanced Biosensing Techniques and Applications (27 papers) and Glycosylation and Glycoproteins Research (14 papers). David G. Myszka is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (49 papers), Advanced Biosensing Techniques and Applications (27 papers) and Glycosylation and Glycoproteins Research (14 papers). David G. Myszka collaborates with scholars based in United States, Australia and United Kingdom. David G. Myszka's co-authors include Rebecca L. Rich, Thomas A. Morton, Irwin Chaiken, Cheryl L. Baird, Wesley I. Sundquist, Yihua Huang, Phinikoula S. Katsamba, Michael L. Doyle, Owen Pornillos and Hao Wu and has published in prestigious journals such as Nature, Science and Cell.

In The Last Decade

David G. Myszka

132 papers receiving 12.8k citations

Hit Papers

Tsg101 and the Vacuolar P... 1999 2026 2008 2017 2001 1999 250 500 750 1000

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
David G. Myszka 9.1k 2.9k 1.8k 1.7k 1.4k 133 13.2k
Rebecca L. Rich 5.1k 0.6× 1.2k 0.4× 873 0.5× 950 0.6× 729 0.5× 71 7.8k
Stephen B. H. Kent 22.2k 2.4× 2.9k 1.0× 1.6k 0.9× 934 0.5× 940 0.7× 261 29.0k
Robert Tampé 8.8k 1.0× 1.3k 0.4× 5.5k 3.1× 1.9k 1.1× 1.1k 0.8× 317 16.9k
T. Alwyn Jones 21.1k 2.3× 1.1k 0.4× 2.4k 1.3× 2.5k 1.5× 2.5k 1.8× 181 29.7k
Florian Μ. Wurm 7.6k 0.8× 1.7k 0.6× 1.1k 0.6× 1.2k 0.7× 260 0.2× 167 10.3k
David R. Davies 14.0k 1.5× 3.7k 1.3× 3.7k 2.1× 398 0.2× 593 0.4× 146 20.1k
Charles S. Craik 10.6k 1.2× 1.2k 0.4× 2.2k 1.2× 545 0.3× 1.2k 0.9× 344 19.6k
R. B. Merrifield 15.5k 1.7× 2.1k 0.7× 1.6k 0.9× 786 0.5× 437 0.3× 179 20.0k
E.A. Stura 5.2k 0.6× 2.0k 0.7× 2.5k 1.4× 264 0.2× 461 0.3× 172 10.4k
Roger S. Goody 13.1k 1.4× 807 0.3× 724 0.4× 501 0.3× 4.7k 3.4× 329 17.8k

Countries citing papers authored by David G. Myszka

Since Specialization
Citations

This map shows the geographic impact of David G. Myszka's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David G. Myszka with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David G. Myszka more than expected).

Fields of papers citing papers by David G. Myszka

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David G. Myszka. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David G. Myszka. The network helps show where David G. Myszka may publish in the future.

Co-authorship network of co-authors of David G. Myszka

This figure shows the co-authorship network connecting the top 25 collaborators of David G. Myszka. A scholar is included among the top collaborators of David G. Myszka based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David G. Myszka. David G. Myszka is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Christopher, J.A., Jason Brown, A.S. Dore, et al.. (2013). Biophysical Fragment Screening of the β 1 -Adrenergic Receptor: Identification of High Affinity Arylpiperazine Leads Using Structure-Based Drug Design. Journal of Medicinal Chemistry. 56(9). 3446–3455. 123 indexed citations
3.
Stadtmueller, Beth M., Erik Kish‐Trier, Katherine Ferrell, et al.. (2012). Structure of a Proteasome Pba1-Pba2 Complex. Journal of Biological Chemistry. 287(44). 37371–37382. 50 indexed citations
4.
Congreve, Miles, et al.. (2011). Fragment Screening of Stabilized G-Protein-Coupled Receptors Using Biophysical Methods. Methods in enzymology on CD-ROM/Methods in enzymology. 493. 115–136. 86 indexed citations
5.
Rich, Rebecca L., Michelle J. Cannon, Jerry Jenkins, et al.. (2007). Extracting kinetic rate constants from surface plasmon resonance array systems. Analytical Biochemistry. 373(1). 112–120. 61 indexed citations
6.
Rich, Rebecca L. & David G. Myszka. (2007). Survey of the year 2006 commercial optical biosensor literature. Journal of Molecular Recognition. 20(5). 300–366. 86 indexed citations
7.
Drake, Andrew W., David G. Myszka, & Scott L. Klakamp. (2004). Characterizing high-affinity antigen/antibody complexes by kinetic- and equilibrium-based methods. Analytical Biochemistry. 328(1). 35–43. 98 indexed citations
8.
Canziani, Gabriela, Scott L. Klakamp, & David G. Myszka. (2004). Kinetic screening of antibodies from crude hybridoma samples using Biacore. Analytical Biochemistry. 325(2). 301–307. 108 indexed citations
9.
Xu, Guozhou, Rebecca L. Rich, Clemens Steegborn, et al.. (2003). Mutational Analyses of the p35-Caspase Interaction. Journal of Biological Chemistry. 278(7). 5455–5461. 23 indexed citations
10.
Rich, Rebecca L. & David G. Myszka. (2003). Spying on HIV with SPR. Trends in Microbiology. 11(3). 124–133. 36 indexed citations
11.
Huang, Yihua, Rebecca L. Rich, David G. Myszka, & Hao Wu. (2003). Requirement of Both the Second and Third BIR Domains for the Relief of X-linked Inhibitor of Apoptosis Protein (XIAP)-mediated Caspase Inhibition by Smac. Journal of Biological Chemistry. 278(49). 49517–49522. 119 indexed citations
12.
Ekstrom, J.L., Thomas Pauly, Maynard D. Carty, et al.. (2002). Structure-Activity Analysis of the Purine Binding Site of Human Liver Glycogen Phosphorylase. Chemistry & Biology. 9(8). 915–924. 47 indexed citations
13.
Santagata, Sandro, Titus J. Boggon, Cheryl L. Baird, et al.. (2001). G-Protein Signaling Through Tubby Proteins. Science. 292(5524). 2041–2050. 302 indexed citations
14.
Huang, Yihua, et al.. (2001). Structural Basis of Caspase Inhibition by XIAP. Cell. 104(5). 781–790. 363 indexed citations
15.
Katsamba, Phinikoula S., David G. Myszka, & Ite A. Laird‐Offringa. (2001). Two Functionally Distinct Steps Mediate High Affinity Binding of U1A Protein to U1 Hairpin II RNA. Journal of Biological Chemistry. 276(24). 21476–21481. 69 indexed citations
16.
Park, Sung‐Min, et al.. (2000). HuD RNA Recognition Motifs Play Distinct Roles in the Formation of a Stable Complex with AU-Rich RNA. Molecular and Cellular Biology. 20(13). 4765–4772. 88 indexed citations
17.
Myszka, David G., Stephen Wood, & Anja Leona Biere. (1999). [25] Analysis of fibril elongation using surface plasmon resonance biosensors. Methods in enzymology on CD-ROM/Methods in enzymology. 309. 386–402. 36 indexed citations
18.
Morton, Thomas A. & David G. Myszka. (1998). [13] Kinetic analysis of macromolecular interactions using surface plasmon resonance biosensors. Methods in enzymology on CD-ROM/Methods in enzymology. 295(2). 268–294. 262 indexed citations
19.
Joss, Lisa, Thomas A. Morton, Michael L. Doyle, & David G. Myszka. (1998). Interpreting Kinetic Rate Constants from Optical Biosensor Data Recorded on a Decaying Surface. Analytical Biochemistry. 261(2). 203–210. 50 indexed citations
20.
Yoo, Sanghee, et al.. (1997). Molecular recognition in the HIV-1 capsid/cyclophilin A complex 1 1Edited by J. A. Wells. Journal of Molecular Biology. 269(5). 780–795. 238 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026